Lipidor AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Public
- Established
- 2009-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.lipidor.se
Efficacy and Safety of Novel Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis
Phase 1
Completed
- Conditions
- Psoriasis Vulgaris
- Interventions
- Drug: AKVANO-Calcipotriol formulation 1Drug: AKVANO-Calcipotriol formulation 2Drug: AKVANO vehicle formulation 1Drug: AKVANO vehicle formulation 2Drug: Daivonex solutionDrug: Daivonex cream
- First Posted Date
- 2022-08-05
- Last Posted Date
- 2022-08-05
- Lead Sponsor
- Lipidor AB
- Target Recruit Count
- 24
- Registration Number
- NCT05488990
- Locations
- 🇩🇪
bioskin GmbH, Bergmannstrasse 5, Berlin, Germany
A Phase III Study in Subjects With Mild to Moderate Psoriasis.
Phase 3
- Conditions
- Mild to Moderate Psoriasis
- Interventions
- First Posted Date
- 2022-02-22
- Last Posted Date
- 2022-08-10
- Lead Sponsor
- Lipidor AB
- Target Recruit Count
- 294
- Registration Number
- NCT05249972
- Locations
- 🇮🇳
Lotus Multispeciality Hospital, Ahmedabad, India
© Copyright 2025. All Rights Reserved by MedPath